2022. Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression. International Journal of Cell and Biomedical Science. 1, 2 (Sep. 2022), 65–69. DOI:https://doi.org/10.59278/cbs.v1i2.19.